| scholarly article | Q13442814 |
| P50 | author | Luca Persano | Q43121424 |
| Alessandro Della Puppa | Q55743591 | ||
| Giuseppe Basso | Q56810716 | ||
| Francesca Pistollato | Q86167451 | ||
| Elena Rampazzo | Q114452190 | ||
| Renato Scienza | Q114452191 | ||
| Sara Abbadi | Q114452195 | ||
| Chiara Frasson | Q114452196 | ||
| P2093 | author name string | Domenico D'avella | |
| Eva Sarto | |||
| P2860 | cites work | Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma | Q28286168 |
| P433 | issue | 5 | |
| P921 | main subject | hypoxia | Q105688 |
| P304 | page(s) | 851-862 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma | |
| P478 | volume | 28 |
| Q38797345 | A comprehensive profile of recurrent glioblastoma |
| Q52646455 | A highlight on Sonic hedgehog pathway. |
| Q39670048 | A microRNA Link to Glioblastoma Heterogeneity |
| Q34723950 | ASYMMETRIC CELL DIVISION: IMPLICATIONS FOR GLIOMA DEVELOPMENT AND TREATMENT. |
| Q36562175 | Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122. |
| Q42317561 | Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells |
| Q37190790 | Analysis of different components in the peritumoral tissue microenvironment of colorectal cancer: A potential prospect in tumorigenesis |
| Q41973667 | Angiogenic signalling pathways altered in gliomas: selection mechanisms for more aggressive neoplastic subpopulations with invasive phenotype |
| Q38840667 | Annexin 2A sustains glioblastoma cell dissemination and proliferation |
| Q36347256 | BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression |
| Q35570253 | Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study |
| Q36562573 | Biological and clinical implications of cancer stem cells in primary brain tumors |
| Q36259173 | Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide. |
| Q42576930 | Brain cancer stem cells: current status on glioblastoma multiforme |
| Q27003138 | Brain tumor stem cells: Molecular characteristics and their impact on therapy |
| Q60949809 | Ca-Dependent Transcriptional Repressors KCNIP and Regulation of Prognosis Genes in Glioblastoma |
| Q26771238 | Cancer Stem Cells and Their Interaction with the Tumor Microenvironment in Neuroblastoma |
| Q37441234 | Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance |
| Q33569712 | Cancer stem cells: a systems biology view of their role in prognosis and therapy |
| Q89964170 | Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway |
| Q36663479 | Cell cycle progression in glioblastoma cells is unaffected by pathophysiological levels of hypoxia |
| Q35828103 | Cellular plasticity regulated cancer stem cell niche: a possible new mechanism of chemoresistance |
| Q38431462 | Chemoresistance and chemotherapy targeting stem-like cells in malignant glioma. |
| Q35521316 | Chemoresistance of glioblastoma cancer stem cells--much more complex than expected |
| Q39354541 | Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma |
| Q42335701 | Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation |
| Q39008713 | Combination treatment with theranostic nanoparticles for glioblastoma sensitization to TMZ. |
| Q28251767 | Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone |
| Q38739262 | Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model |
| Q64085212 | Distinct Tumor Microenvironment at Tumor Edge as a Result of Astrocyte Activation Is Associated With Therapeutic Resistance for Brain Tumor |
| Q91679510 | Effects of Far-infrared Ray on Temozolomide-treated Glioma in Rats |
| Q30048454 | Elimination of Cancer Stem-Like Cells and Potentiation of Temozolomide Sensitivity by Honokiol in Glioblastoma Multiforme Cells |
| Q26849477 | Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach |
| Q33894470 | Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models |
| Q90440161 | Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma |
| Q36723770 | Fusicoccin a, a phytotoxic carbotricyclic diterpene glucoside of fungal origin, reduces proliferation and invasion of glioblastoma cells by targeting multiple tyrosine kinases |
| Q93155087 | GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets |
| Q35160410 | Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor |
| Q26765869 | Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance |
| Q26776219 | Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma |
| Q64056689 | Glioblastoma Stem- Cells, Metabolic Strategy to Kill a Challenging Target |
| Q35719080 | Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment |
| Q42090570 | Glioblastoma heterogeneity and more accurate representation in research models. |
| Q38182805 | Glioblastoma multiforme: a look inside its heterogeneous nature |
| Q55457162 | Glioblastoma niches: from the concept to the phenotypical reality. |
| Q35794896 | Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs. |
| Q90706161 | Glioblastoma: Microenvironment and Niche Concept |
| Q47867713 | Glioma Stem Cell Niches in Human Glioblastoma Are Periarteriolar |
| Q26765758 | Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets |
| Q26765854 | Glioma Stem Cells: Signaling, Microenvironment, and Therapy |
| Q37914244 | Glioma stem cell maintenance: the role of the microenvironment |
| Q28078559 | Glucose transport: meeting the metabolic demands of cancer, and applications in glioblastoma treatment |
| Q92604874 | HIF-1α/Wnt signaling-dependent control of gene transcription regulates neuronal differentiation of glioblastoma stem cells |
| Q33709584 | HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia |
| Q47100546 | Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma |
| Q92811055 | Human Medulloblastoma Cell Lines: Investigating on Cancer Stem Cell-Like Phenotype |
| Q39319634 | Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide. |
| Q51636063 | Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML. |
| Q39174318 | Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas. |
| Q59134257 | Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma |
| Q42284347 | Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme |
| Q24306474 | Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex |
| Q91152926 | Importance of GFAP isoform-specific analyses in astrocytoma |
| Q36645642 | In vitro expansion of human glioblastoma cells at non-physiological oxygen tension irreversibly alters subsequent in vivo aggressiveness and AC133 expression |
| Q48583242 | Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells |
| Q37790338 | Insight into the complex regulation of CD133 in glioma |
| Q37274612 | Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma |
| Q35986799 | Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells |
| Q64076906 | Low perfusion compartments in glioblastoma quantified by advanced magnetic resonance imaging and correlated with patient survival |
| Q42700764 | M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma |
| Q49093913 | MGMT expression and promoter methylation status may depend on the site of surgical sample collection within glioblastoma: a possible pitfall in stratification of patients? |
| Q38218848 | MGMT testing--the challenges for biomarker-based glioma treatment |
| Q37581947 | Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules |
| Q50352642 | Multiscale Modeling of Glioblastoma Suggests that the Partial Disruption of Vessel/Cancer Stem Cell Crosstalk Can Promote Tumor Regression Without Increasing Invasiveness |
| Q58695662 | Nanotechnology for treatment of glioblastoma multiforme |
| Q38154066 | New treatment strategies to eradicate cancer stem cells and niches in glioblastoma |
| Q93369543 | Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells |
| Q89497366 | O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy |
| Q36096925 | O6-Methylguanine-methyltransferase (MGMT) promoter methylation status in glioma stem-like cells is correlated to temozolomide sensitivity under differentiation-promoting conditions |
| Q37978771 | Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches. |
| Q36644898 | Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy |
| Q34806788 | Peritoneal milky spots serve as a hypoxic niche and favor gastric cancer stem/progenitor cell peritoneal dissemination through hypoxia-inducible factor 1α. |
| Q44737792 | Phenotypic and functional characterization of Glioblastoma cancer stem cells identified through 5-aminolevulinic acid-assisted surgery [corrected]. |
| Q50054057 | Plasticity in Glioma Stem Cell Phenotype and Its Therapeutic Implication |
| Q39090430 | Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM. |
| Q55513476 | Quiescence status of glioblastoma stem-like cells involves remodelling of Ca2+ signalling and mitochondrial shape. |
| Q94495177 | Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas |
| Q35992355 | Recent developments on immunotherapy for brain cancer |
| Q34478948 | Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review). |
| Q27314916 | Short-Term Differentiation of Glioblastoma Stem Cells Induces Hypoxia Tolerance |
| Q38078705 | Signals that regulate the oncogenic fate of neural stem cells and progenitors |
| Q47966116 | Standardized uptake value in high uptake area on positron emission tomography with 18F-FRP170 as a hypoxic cell tracer correlates with intratumoral oxygen pressure in glioblastoma |
| Q38566898 | Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles |
| Q55309955 | The Adenosine A₃ Receptor Regulates Differentiation of Glioblastoma Stem-Like Cells to Endothelial Cells under Hypoxia. |
| Q44033285 | The Role of Protein Kinase B Signaling Pathway in Anti-Cancer Effect of Rolipram on Glioblastoma Multiforme: An In Vitro Study |
| Q64095945 | The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion |
| Q64097360 | The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells |
| Q36795940 | The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence |
| Q26829663 | The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications |
| Q55287129 | Transcriptional Repression of p53 by PAX3 Contributes to Gliomagenesis and Differentiation of Glioma Stem Cells. |
| Q93351016 | Tumour heterogeneity and metastasis at single-cell resolution |
| Q33903166 | Wnt activation promotes neuronal differentiation of glioblastoma |
| Q53059683 | microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells. |
Search more.